OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Pre-Tax Margin

Income before tax as a percentage of revenue.

OraSure Technologies, Inc.NASDAQ: OSUR

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -81.7%

Pre-tax margin was -81.7% in Q1 FY2026, down 26.6 pp from a year earlier. On a trailing-twelve-month basis it was -64.8%, down 45.9 pp year over year. Over 3 fiscal years it narrowed by 54.1 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-81.7%-10.4 pp QoQ
Last fiscal yearDec 2025
-58.2%-48.7 pp YoY
LTMMar 2026
-64.8%-45.9 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-26.6 pp——
1 year-48.7 pp——
3 years-54.1 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-58.2%
Year-over-year change
-48.7pp

Pre-Tax Margin vs competitors

How OSUR compares with its peers on the latest reported figures

  • OSUR's LTM Mar 2026 pre-tax margin of -64.8% is the 4th highest of the 8 companies compared; the peer median is -206.5%.
  • Its year-over-year change of -45.9 pp is the 6th highest of 7, against a peer median of +47.3 pp.
  • Over three fiscal years its change of -54.1 pp compares with a peer median of +58.3 pp.
OSUR Competitors Peer median
Pre-Tax Margin for OSUR and competitors
Company Period LTM level YoY 3-year change
UTMDUtah Medical Products, Inc.LTM Mar 202635.8% -4.6 pp-2.9 pp
STIMNeuronetics, Inc.LTM Mar 2026-24.6% +29.8 pp+30.9 pp
PREPrenetics Global LimitedLTM Mar 2026-64.5% +78.3 pp+1676.2 pp
OSUROraSure Technologies, Inc.LTM Mar 2026-64.8% -45.9 pp-54.1 pp
PROFProfound Medical Corp.LTM Mar 2026-206.5% +64.8 pp+161.9 pp
NYXHNyxoah S.A.LTM Mar 2026-519.6% +1013.3 pp+85.6 pp
CATXPerspective Therapeutics, Inc.LTM Mar 2026-18194.2% -12290.7 pp-11606.6 pp
NTHINeonc Technologies Holdings, Inc.FY2025-155404.4% ——
NAUTNautilus Biotechnology, Inc.FY2025— ——
TARAProtara Therapeutics, Inc.FY2025— ——
Peer median (excluding OSUR) -206.5%+47.3 pp+58.3 pp

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.67M387.48M405.47M185.83M115.02M
Cost of Revenue116.07M239.04M226.05M109.6M66.82M
Gross Profit117.6M148.44M179.42M76.23M48.2M
Gross Margin50.3%38.3%44.2%41.0%41.9%
Research & Development34.17M36.24M33.16M24.42M42.53M
Selling, General & Admin95.08M117.44M92.18M72.41M73.79M
Operating Expenses129.25M153.68M125.34M96.83M116.32M
Depreciation & Amortization11.66M14M19.9M10.87M9.97M
EBITDA2.37M(1.68M)76.16M(6.83M)(56.96M)
EBITDA Margin1.0%-0.4%18.8%-3.7%-49.5%
Operating Income(11.65M)(5.24M)54.08M(20.6M)(68.12M)
Operating Margin-5.0%-1.4%13.3%-11.1%-59.2%
Interest Income00000
Interest Expense00000
Other Income / Expenses2.36M(10.43M)2.18M2.9M1.19M
Income Before Tax(9.29M)(15.68M)56.26M(17.7M)(66.93M)
Pre-Tax Margin-4.0%-4.0%13.9%-9.5%-58.2%
Income Tax Expense13.71M1.46M2.6M1.8M1.8M
Net Income(23M)(17.13M)53.66M(19.5M)(68.73M)
Net Margin-9.8%-4.4%13.2%-10.5%-59.8%
EPS (Basic)(0.32)(0.25)0.73(0.26)(0.94)
EPS (Diluted)(0.32)(0.25)0.72(0.26)(0.94)
Weighted Avg Shares71.98M72.51M73.35M74.43M73.49M
Weighted Avg Shares (Diluted)71.98M72.51M74.39M74.43M73.49M

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.